Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
Status:
Terminated
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of hydrocortisone
ophthalmic ointment compared to placebo in the treatment of Allergic Conjunctivitis.